NCT00211224View on ClinicalTrials.gov

Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)

PHASE3TerminatedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

November 30, 2004

Conditions
Multiple System AtrophyProgressive Supranuclear Palsy
Interventions
DRUG

Riluzole

Trial Locations (1)

SE58AF

Institute of Psychiatry, King's College London, London

Sponsors

Collaborators (1)

Aventis Pharmaceuticals
All Listed Sponsors
collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

University of Ulm

OTHER

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

King's College London

OTHER